Phathom Pharmaceuticals Inc (PHAT)
17.52
-0.30
(-1.68%)
USD |
NASDAQ |
Sep 27, 16:00
17.52
0.00 (0.00%)
After-Hours: 20:00
Phathom Pharmaceuticals Cash from Financing (Quarterly): 24.77M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 24.77M |
| March 31, 2024 | 9.90M |
| December 31, 2023 | 211.99M |
| September 30, 2023 | 0.013M |
| June 30, 2023 | 141.50M |
| March 31, 2023 | 14.07M |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 24.60M |
| June 30, 2022 | 95.45M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.163M |
| Date | Value |
|---|---|
| September 30, 2021 | 44.03M |
| June 30, 2021 | 0.104M |
| March 31, 2021 | 0.412M |
| December 31, 2020 | 89.46M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 25.00M |
| December 31, 2019 | 192.77M |
| September 30, 2019 | -1.299M |
| June 30, 2019 | 113.17M |
| March 31, 2019 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.299M
Minimum
Sep 2019
211.99M
Maximum
Dec 2023
43.65M
Average
11.99M
Median
Cash from Financing (Quarterly) Benchmarks
| Fortress Biotech Inc | 14.26M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -70.72M |
| Cash from Investing (Quarterly) | -0.046M |
| Free Cash Flow | -216.95M |
| Free Cash Flow Per Share (Quarterly) | -1.208 |
| Free Cash Flow to Equity (Quarterly) | -96.17M |
| Free Cash Flow Yield | -21.44% |